Advertisement

Adenosine Receptors on Human Inflammatory Cells

  • Gianni Marone
  • Rosaria Petracca
  • Mario Condorelli
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)

Abstract

Adenosine, a naturally occurring purine nucleoside, plays an important role in controlling a variety of biological activities. Adenosine is formed within cells from AMP or from the degradation of S-adenosylhomocysteine and can be removed from cells by release into the extracellular fluid, by deamination to inosine, or by reutilization to form AMP (1). Adenosine is present in human blood and in post of the extracellular fluid at levels (3 × 10−7 M to 3 × 10−6 M) which in vitro modulate several biochemical and biological functions (2).

Keywords

Adenosine Receptor Histamine Release Human Lymphocyte Adenosine Deaminase cAMP Accumulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. Salvatore, E. Borek, V. Zappia, H.G. Williams-Ashman, and F. Schlenk, “The Biochemistry of Adenosylmethionine”, Columbia University Press, New York (1977).Google Scholar
  2. 2.
    G. Marone, M. Plaut, and L.M. Lichtenstein, The role of adenosine in the control of immune function, Ric. Clin. Lab. 10: 303 (1980).Google Scholar
  3. 3.
    R. Hirschhorn and D.W.Jr. Martin, Enzyme defects in immunodefi- ciency diseases, Semin. Immunopathol. 1: 299 (1978).Google Scholar
  4. 4.
    F. Ambrogi, B.Grassi, S. Ronca-Testoni, and G. Ronca, Bood lymphocytes in chronic lymphocytic leukaemia and Hodgkin’s disease: immunological features and enzymes of nucleoside metabolism., Clin. Exp. Immunol. 28: 80 (1977).PubMedGoogle Scholar
  5. 5.
    F.C. Schmalstieg, J.A. Nelson, G.C. Mills, T.M. Monahan, A.S. Goldman, and R.M. Goldblum, Increased purine nucleotides in a adenosine deaminase-deficient lymphocytes, J. Pediat. 91: 48 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    J.F. Kuttesch, F.C. Schmalstieg, and J.A. Nelson, Analysis of adenosine and other adenine compounds in patients with immunodeficiency diseases, J. Liquid Chromatogr. 1: 97 (1978).CrossRefGoogle Scholar
  7. 7.
    G. Wolberg, T.P. Zimmerman, K. Hiemstra, M. Winston, and L.C. Chu, Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate, Science 187: 957 (1975).PubMedCrossRefGoogle Scholar
  8. 8.
    J. Uberti, J.J. Lightbody, and R.M. Johnson, The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation, J. Immunol. 123: 189 (1979).PubMedGoogle Scholar
  9. 9.
    R. Hirschhorn, J. Grossman, and G. Weissmann, Effect of cyclic 3’,5’-adenosine monophosphate and theophylline on lymphocyte transformation, Proc. Soc. Exp. Biol. Med. 133: 1361 (1970).PubMedGoogle Scholar
  10. 10.
    G. Marone, M. Plaut, and L.M. Lichtenstein, Characterization of a specific adenosine receptor on human lymphocytes, J. Immunol. 121: 2153 (1978).PubMedGoogle Scholar
  11. 11.
    J.N. Fain and C.C. Malbon, Regulation of adenylate cyclase by adenosine, Mol. Cell. Biochem. 25: 143 (1979).CrossRefGoogle Scholar
  12. 12.
    D.A. Carson and J.E. Seegmiller, Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis, J. Clin. Invest. 57: 274 (1976).PubMedCrossRefGoogle Scholar
  13. 13.
    J.W. Smith, A.L. Steiner, and C.W. Parker, Human lymphocyte metabolism. Effects of cyclic and non-cyclic nucleotides on stimulation by phytohemagglutinin, J. Clin. Invest. 50: 442 (1971).PubMedCrossRefGoogle Scholar
  14. 14.
    M.C. Pike, N.M. Kredich, and R. Snyderman, Requirement of Sadenosyl-L-methionine-mediated methylation for human monocyte chemotaxis, Proc. Natl. Acad. Sci. 75: 3928 (1978).PubMedCrossRefGoogle Scholar
  15. 15.
    G. Marone, S. Findlay, and L.M. Lichtenstein, Adenosine receptor on human basophils: modulation of histamine release, J. Immunol. 123: 1473 (1979).PubMedGoogle Scholar
  16. 16.
    G. Marone, R. Snyderman, and L.M. Lichtenstein, Modulation of IgE-mediated basophil histamine release by adenosine and by two adenosine analogs, in: XI Congress of the European Academy of Allergology and Clinical Immunology, 1980.Google Scholar
  17. 17.
    G. Marone, M. Valentine, and L.M. Lichtenstein, Modulation of cyclic AMP in human leukocytes by physiological doses of adenosine, Fed. Proc. 37: 1688 (1978).Google Scholar
  18. 18.
    G. Marone, M. Plaut, S. Findlay, and L.M. Lichtenstein, The adenosine receptor on human leukocytes, in: First International Colloquium on Receptors, Capri, 1979.Google Scholar
  19. 19.
    J.W. Daly, R.F. Bruns, and S.H. Snyder, Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines, Life Sciences 28: 2083 (1981).PubMedCrossRefGoogle Scholar
  20. 20.
    L.M. Lichtenstein, Mediators and mechanisms of release from purified human basophils and mast cells, in: The American Academy of Allergy, Montreal, 1982.Google Scholar
  21. 21.
    D. van Calker, M. Muller, and Hamprecht, Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells, Nature 276: 839 (1978).PubMedCrossRefGoogle Scholar
  22. 22.
    R.F. Bruns, J.W. Daly, and S.H. Snyder, Adenosine receptors in brain membrnes: binding of N6-cyclohexyl(3H)adenosine and 1,3diethy1–8-(H)phenylxanthine, Proc. Natl. Acad. Sci. 77: 5547 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    T. Trost and U. Schwabel Adenosine receptors in fat cells. Identification by (-)-Nb-(3H)phenylisopropyladenosine binding. Molec. Pharmacol. 19: 228 (1981).Google Scholar
  24. 24.
    C. Moroz and R.H.Stevens, Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in-vitro treatment with adenosine, Clin. Immunol. Immunopathol. 15: 44 (1980).CrossRefGoogle Scholar
  25. 25.
    C. Londos and J. Wolff, Two distinct adenosine-sensitive sites on adenylate cyclase, Proc. Natl. Acad. Sci. 74: 5482 (1977).PubMedCrossRefGoogle Scholar
  26. 26.
    R.J. Haslam, M.M.L. Davidson, and J.V. Desjardins, Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Biochem. J. 176: 83 (1978).PubMedGoogle Scholar
  27. 27.
    R. Tung, R. Silber, F. Quagliata, M. Conklyn, J. Gottesman, and R. Hirschhorn, Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J.Clin. Invest. 57: 756 (1976).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Gianni Marone
    • 1
  • Rosaria Petracca
    • 1
  • Mario Condorelli
    • 1
  1. 1.Department of MedicineUniversity of Naples II School of MedicineNaplesItaly

Personalised recommendations